首页|基于网络药理学方法和分子对接技术探讨芪蛭降糖胶囊治疗糖尿病肾病的作用机制

基于网络药理学方法和分子对接技术探讨芪蛭降糖胶囊治疗糖尿病肾病的作用机制

扫码查看
目的:利用网络药理学方法和分子对接技术探究芪蛭降糖胶囊治疗糖尿病肾病(DN)的药理机制.方法:采用Coremine Medical数据库检索得到利用芪蛭降糖胶囊治疗的相关疾病,验证组方的合理性.由TCMSP、TCM data-base@Taiwan、TCMID数据库检索得到芪蛭降糖胶囊中各单味中药的化学成分,通过"类药五原则"结合文献筛选出137个活性成分.利用HitPick、Similarity ensemble approach、SwissTargetPrediction分析平台获得活性成分可能作用的靶点,通过OMIM、GenCards、DisGeNET数据库获得DN相关靶点,二者取交集,得到127个共同靶点.将共同靶点经GCBI数据库映射到疾病,验证其在糖尿病肾病中的重要性.使用Cytoscape软件构建芪蛭降糖胶囊活性成分-靶点网络,使用STRING平台构建芪蛭降糖胶囊活性成分靶点-DN靶点相互作用网络.使用DAVID软件将共同靶点进行GO功能分析和KEGG通路富集分析.根据化合物和蛋白的相关节点参数结合文献报道,对核心化合物和核心靶点进行分子对接.结果:芪蛭降糖胶囊主要作用于ALB、IL 6、VEGFA、TNF、Akt1靶点,参与HIF-1、TNF、Toll-like receptor信号通路治疗DN.芪蛭降糖胶囊中核心活性成分阿魏酸、槲皮素、毛蕊花糖苷、咖啡酸和芒柄花黄素与核心靶点ALB、IL 6、VEGFA、TNF、Akt1有良好的亲和力.结论:芪蛭降糖胶囊可能通过调控氧化应激、炎症反应、细胞凋亡、免疫调节等,改善肾组织和血管病理损伤,从而起到治疗DN的作用.
Exploration of the mechanism of Qizhi Jiangtang Capsule in the treatment of diabetic nephropathy based on network pharmacology and molecular docking technology
Objective:To explore the pharmacological mechanism of Qizhi Jiangtang Capsule in the treatment of dia-betic nephropathy(DN)by network pharmacology and molecular docking technology.Methods:Coremine Medical data-base was used to search the related diseases treated with Qizhi Jiangtang Capsule to verify the rationality of the prescription.The chemical components of each single Chinese herb in Qizhi Jiangtang Capsule were retrieved from TCMSP,TCM data base@Taiwan and TCMID databases,and combined with the literature,137 active ingredients were screened by"five prin-ciples of similar drugs".The possible targets of active ingredients were obtained through HitPick,Similarity ensemble ap-proach and SwissTargetPrediction analysis platform.The DN-related targets were obtained from OMIM,GenCards and Dis-GeNET databases.By taking the intersection of the possible targets and DN-related targets,127 common targets were ob-tained.Common targets were mapped to diseases via the GCBI database to verify their importance in DN.Cytoscape software was used to construct the active ingredient-target network of Qizhi Jiangtang Capsule,and the STRING platform was used to construct the interaction network between the active ingredient target-DN target of Qizhi Jiangtang Capsule.DAVID soft-ware was used to perform GO functional analysis and KEGG pathway enrichment analysis of the common targets.Molecular docking of core compounds and core targets was performed based on the relevant node parameters of compounds and pro-teins as well as literature reports.Results:Qizhi Jiangtang Capsule mainly acted on the targets of ALB,IL6,VEGFA,TNF and Akt1,and participated in HIF-1,TNF and Toll-like receptor signaling pathways in the treatment of DN.The core ac-tive ingredients of Qizhi Jiangtang Capsule,ferulic acid,quercetin,verbascoside,caffeic acid and formononetin,had good affinity with the core targets ALB,IL6,VEGFA,TNF and Akt1.Conclusion:Qizhi Jiangtang Capsule may improve renal tissues and vascular pathological injury by regulating oxidative stress,inflammatory response,apoptosis,immune regula-tion,etc.,thus playing a role in the treatment of DN.

Qizhi Jiangtang CapsuleDNnetwork pharmacologymolecular docking

史静超、杭薇、高耀、周文静、柴智

展开 >

山西中医药大学中药与食品工程学院,山西 晋中 030619

山西中医药大学基础医学院,山西 晋中 030619

山西大学中医药现代研究中心,山西 太原 030006

芪蛭降糖胶囊 糖尿病肾病 网络药理 分子对接

山西省重点研发计划项目山西省青年拔尖人才支持计划项目山西中医药大学科技创新团队

201803D31091晋组办字[2019]35号文2018TD-012

2024

山西中医药大学学报

山西中医药大学学报

ISSN:
年,卷(期):2024.25(4)